Phase II study of mFOLFOX with bevacizumab (Bev) in metastatic gastroesophageal and gastric (GE) adenocarcinoma (AC).
Jia Li
No relevant relationships to disclose
Jeremy S. Kortmansky
No relevant relationships to disclose
Neal A. Fischbach
No relevant relationships to disclose
Stacey Stein
No relevant relationships to disclose
Xiaopan Yao
No relevant relationships to disclose
Howard S. Hochster
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Jill Lacy
No relevant relationships to disclose